A hemoglobin A1c electrophoresis test is one of the most important tools today in monitoring diabetes. During this process of electrophoresis, hemoglobin molecules are moved across an electric field. Because of their varying electrical charges, the different types of hemoglobin will separate into several different “bands.” A comparison of the hemoglobin A1c band after electrophoresis compared to a normal blood sample will determine how the body’s blood sugar has been regulated during the past 120 days (the length of time red blood cells circulate). The higher the intra-erythrocyte glucose concentration or glycated hemoglobin, the heavier the hemoglobin A1c band.

Diabetes currently affects more than 150 million people worldwide, with that number expected to double to 300 million by 2025. Uncontrolled diabetes can lead to major health problems, including kidney damage, blindness, heart attract, and stroke, so the treatment and monitoring of this disease is absolutely necessary. At Sebia, we pride ourselves on being an industry leader in the production of tools – including the HYDRASYS^®, a semi-automated electrophoresis system with a Hemoglobin A1c assay – that can accurately and cost-effectively help monitor hemoglobin A1c levels.

To find out more about exciting upcoming advancements concerning electrophoretic hemoglobin A1c testing, please contact us today.